Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
SANKO, 39% Decrease in Ordinary Profit for The Current Fiscal Year
6964 SANKO CO.,LTD. 【J-GAAP】
Earnings ReportSANKO CO.,LTD. <6964> [TSE Std] announced its financial results after the market closed on May 9th (16:00). The consolidated ordinary profit for the fiscal year ending March 2025 decreased 17.6% from the previous period to 815 million yen. For the fiscal year ending March 2026, the consolidated ordinary profit is expected to drop by 38.7% from the previous period to 500 million yen.
In the most recent three-month period, from January to March (4Q), the consolidated ordinary profit significantly dropped to 86 million yen, a 55.7% decrease compared to the same period last year. The operating profit margin worsened from 2.9% in the same period last year to 1.7%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2023 | 15,674 | 494 | 568 | 420 | 47.3 | 13 | May 12, 2023 | J-GAAP |
| Mar, 2024 | 16,936 | 771 | 989 | 704 | 79.4 | 22 | May 10, 2024 | J-GAAP |
| Mar, 2025 | 16,838 | 546 | 815 | 569 | 64.2 | 20 | May 9, 2025 | J-GAAP |
| YoY | -0.6% | -29.2% | -17.6% | -19.2% | -19.2% |
Full Year Results vs. Previous Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2025 Guidance | 17,000 | 500 | 770 | 550 | 62.0 | 20 | Feb 7, 2025 | J-GAAP |
| Mar, 2025 Results | 16,838 | 546 | 815 | 569 | 64.2 | 20 | May 9, 2025 | J-GAAP |
| Revision Rate | -1.0% | +9.2% | +5.8% | +3.5% | +3.6% |
Current Period Guidance
H1 Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Sep, 2024 | 8,127 | 266 | 326 | 230 | 26.0 | 0 | Nov 8, 2024 | J-GAAP |
| Apr - Sep, 2025 Guidance | 8,000 | 200 | 250 | 170 | 19.2 | 0 | May 9, 2025 | J-GAAP |
| YoY | -1.6% | -24.8% | -23.3% | -26.1% | -26.2% |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2024 | 16,936 | 771 | 989 | 704 | 79.4 | 22 | May 10, 2024 | J-GAAP |
| Mar, 2025 | 16,838 | 546 | 815 | 569 | 64.2 | 20 | May 9, 2025 | J-GAAP |
| Mar, 2026 Guidance | 16,500 | 450 | 500 | 350 | 39.4 | 20 | May 9, 2025 | J-GAAP |
| YoY | -2.0% | -17.6% | -38.7% | -38.5% | -38.6% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan - Mar, 2024 | 3,952 | 116 | 194 | 146 | 16.5 | 2.9 | May 10, 2024 | J-GAAP |
| Apr - Jun, 2024 | 3,998 | 96 | 115 | 87 | 9.8 | 2.4 | Aug 9, 2024 | J-GAAP |
| Jul - Sep, 2024 | 4,129 | 170 | 211 | 143 | 16.2 | 4.1 | Nov 8, 2024 | J-GAAP |
| Oct - Dec, 2024 | 4,292 | 206 | 403 | 297 | 33.5 | 4.8 | Feb 7, 2025 | J-GAAP |
| Jan - Mar, 2025 | 4,419 | 74 | 86 | 42 | 4.7 | 1.7 | May 9, 2025 | J-GAAP |
| YoY | +11.8% | -36.2% | -55.7% | -71.2% | -71.2% |
Related Articles
TB GROUP, Last Fiscal Year's Net Income Loss Narrows, Current period performance is undisclosed.
HOKKAIDO COCACOLA, Jan-Mar (1Q) Ordinary Profit Increases by 53%
SUN-WA TECHNOS, 1% Decrease in Ordinary Profit for The Current Fiscal Year
NICHIMO, 3% Decrease in Ordinary Profit for The Current Fiscal Year, Increased Previous Year's Dividend by 7 yen, This Fiscal Year to Increase Dividend by 3 yen
YAMAZAKI, 17% Decrease in Ordinary Profit for The Current Fiscal Year
NAKAYO, Last Fiscal Year's Ordinary Profit Loss Narrows, Current period performance is undisclosed.
Carna Biosciences, Jan-Mar (1Q) Ordinary Profit Loss Widens
KAWADEN, 3% Decrease in Ordinary Profit for The Current Fiscal Year
Furubayashi Shiko, Jan-Mar (1Q) Ordinary Profit Turns to Profit
WILL GROUP, Last Fiscal Year Net Income Revised Downward by 30%